[Anabolic effect of a new non-hormonal drug].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000856:Anorexia Nervosa / Q000188:drug therapy; D001769:Blood / Q000187:drug effects; D001798:Blood Proteins / Q000096:biosynthesis; D001835:Body Weight / Q000187:drug effects; D003038:Cobamides / Q000627:therapeutic use; D003067:Coenzymes / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D001068:Feeding and Eating Disorders / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006452:Hemoglobinometry; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D014805:Vitamin B 12 / Q000627:therapeutic use*
D001798:Blood Proteins; D003038:Cobamides; D003067:Coenzymes; D014805:Vitamin B 12
Sull'azione anabolizzante di un nuovo farmaco non ormonale.